Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
2 Growth Stocks That Could Jump 64.1% to 86.1% Higher, According to Wall Street
06:09am, Monday, 03'rd Oct 2022
Investment bank analysts think both of these stocks have what they need to deliver big gains in the foreseeable future.
Moderna turns down China request for vaccine technology: report
03:30am, Sunday, 02'nd Oct 2022
Moderna has so far refused to make a deal for its COVID-19 vaccine with China, due to Beijing wanting the intellectual property behind it.
Moderna refused China request to reveal vaccine technology, Financial Times reports
08:05pm, Saturday, 01'st Oct 2022
Moderna Inc has refused to hand over to China the core intellectual property behind the development of its COVID-19 vaccine, leading to a collapse in negotiations on its sale there, the Financial Time
Here's Why the Post-Pandemic World May Be Even Better for This Vaccine Maker
06:00am, Saturday, 01'st Oct 2022
Moderna's billion-dollar revenue may be just getting started.
Why Moderna Was a Sickly Stock Today
06:20pm, Thursday, 29'th Sep 2022
A shuffle at the top of the executive ranks, combined with the continued decline of the coronavirus, rattles some investors.
EMA Accepts Moderna's (MRNA) Filing for Omicron BA.4, BA.5 Booster
01:33pm, Thursday, 29'th Sep 2022
The EMA accepts Moderna's (MRNA) regulatory filing seeking authorization for bivalent COVID-19 booster vaccine, mRNA-1273.222, designed to target the Omicron BA.4 and BA.5 subvariants.
These 2 Growth Stocks Have Fallen Out of Grace. Are They Buys?
09:45am, Thursday, 29'th Sep 2022
These vaccine makers have lost much of the momentum they built earlier in the pandemic.
Why Moderna Stock Lagged the Market Today
05:28pm, Wednesday, 28'th Sep 2022
The company's latest regulatory advance is overshadowed by developments with another biotech.
7 Growth Stocks to Buy Before the Bull Market Returns
06:45am, Wednesday, 28'th Sep 2022
In this market slowdown there appear to be fewer growth stocks to buy, but patience will be rewarded. It's been a forgettable year, to say the least, for equity investors.
Why Moderna Stock Crushed the Market Today
04:58pm, Tuesday, 27'th Sep 2022
Investors cheered some positive news on the vaccine supply front.
Covid-Related Sales Boost BioNTech, Moderna and Gilead
03:21pm, Tuesday, 27'th Sep 2022
Covid-related product sales helped make BioNTech SE ( BNTX , Financial), Moderna Inc. ( MRNA , Financial), Gilead Sciences Inc. ( GILD , Financial) and Regeneron Pharmaceuticals Inc. ( REGN , Financia
Down 85%, Is There Any Hope for This Struggling Vaccine Stock?
06:00am, Monday, 26'th Sep 2022
The problem? Novavax arrived late to the market.
Better Growth Stock: Moderna vs. Teladoc
06:30am, Saturday, 24'th Sep 2022
Both of these stocks are looking pretty cheap.
General Mills, Meta Platforms, Moderna: Stocks That Defined the Week
07:02pm, Friday, 23'rd Sep 2022
Here are seven major companies whose stocks moved on the week's news.
Moderna asks FDA to authorize omicron Covid boosters for children as young as 6 years old
12:08pm, Friday, 23'rd Sep 2022
Moderna has asked the FDA to authorize omicron boosters for adolescents ages 12 to 17-years-old and for kids ages 6 to 11-years-old.
